Skip to content

Talphera, Inc. TLPH Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-$28.35M-1,019%
PTH
Pelthos Therapeutics Inc.PTHS
-$1.91M
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
-$5.91M-43.5%
Theravance Biopharma logo
Theravance BiopharmaTBPH
-$4.87M-221%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$683K-84.6%

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Operating income-$3.9M-35.4%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-
Free cash flow-$2.3M+42.9%

Valuation

See full
Market cap$53.46M+516%
P/S53,456.6×+53,135×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Reported directly by Talphera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: Talphera, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s change in accrued liabilities?
Talphera, Inc. (TLPH) reported change in accrued liabilities of -$252K in Q1 2026.
How has Talphera, Inc.'s change in accrued liabilities changed year-over-year?
Talphera, Inc.'s change in accrued liabilities increased by 19.5% year-over-year, from -$313K to -$252K.
What does change in accrued liabilities mean?
Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.